VanDommelen, K., Brihn, L., Calabrese, C., Zhou, K., MD, M. S., Abdoh, M., Kunchok, A., Philpott, J., Junna, S., Kabbur, G., Owoyemi, I., Truong, T., Gupta, S., Moore, H. C. F., Pennell, N. A., Ma, W. W., Funchain, P., Kennedy, L. B. (2025). Use of steroid-sparing agents (SSAs) for immune-related adverse events (irAEs) in patients (pts) discussed at a multidisciplinary immune-related adverse event (irAE) tumor board.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e24112